Review of cancer treatment with immune checkpoint inhibitors: Current concepts, expectations, limitations and pitfalls

Immunotherapy by checkpoint inhibition is about to profoundly change cancer therapy. The number of indications are growing at an unprecedented speed. Clinical studies have demonstrated efficacy in a variety of solid tumors and in hematologic malignancies, although some clinical trials have produced...

Descripción completa

Detalles Bibliográficos
Autores principales: Thallinger, Christiane, Füreder, Thorsten, Preusser, Matthias, Heller, Gerwin, Müllauer, Leonhard, Höller, Christoph, Prosch, Helmut, Frank, Natalija, Swierzewski, Rafal, Berger, Walter, Jäger, Ulrich, Zielinski, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816095/
https://www.ncbi.nlm.nih.gov/pubmed/29098404
http://dx.doi.org/10.1007/s00508-017-1285-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816095/
https://www.ncbi.nlm.nih.gov/pubmed/29098404
http://dx.doi.org/10.1007/s00508-017-1285-9

Ejemplares similares